CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- CORRESP Other Correspondence Between Filers and SEC Staff
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award SVP, FINANCE AND CAO acquired 3,000 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 42,000 shares (grant or award)
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Exit or restructuring costs · Executive or director change
- 4 Open-market sale SVP, FINANCE AND CAO sold 550 shares at $1.15 ($633)
- 4 Open-market sale PRESIDENT & CSO sold 1,326 shares at $1.15 ($1,525)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 2,159 shares at $1.15 ($2,483)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 22 · 421 filings